Genpact (NYSE:G) Price Target Raised to $45.00

Дата публикации: 10-08-2026 05:36:50

Genpact (NYSE:G – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $40.00 to $45.00 in a report released on Friday,Benzinga reports. They currently have a neutral rating on the business services provider’s stock. Other equities analysts have also recently issued research reports about the company. BMO Capital Markets restated a […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Qiagen (NYSE:QGEN) Price Target Raised to $50.00	0	14.26	10-08-2026
2	Target (NYSE:TGT) Price Target Raised to $157.00	0	13.85	10-08-2026
3	TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00	0	13.04	10-08-2026
4	Banco De Chile (NYSE:BCH) Price Target Raised to $45.00	0	14.2	10-08-2026
5	Cadre (NYSE:CDRE) Price Target Raised to $45.00	0	13.85	10-08-2026
6	Genmab A/S (NASDAQ:GMAB) Price Target Raised to $42.00	0	9.76	10-08-2026
7	PAR Technology (NYSE:PAR) Price Target Raised to $18.00	0	14.24	10-08-2026
8	JFrog (NASDAQ:FROG) Price Target Raised to $115.00	0	14.6	10-08-2026
9	Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00	0	13.83	10-08-2026
10	Allient (NASDAQ:ALNT) Price Target Raised to $120.00	0	13.06	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.26. Источник: www.americanbankingnews.com.